Allurion to increase focus on low-dose GLP-1 combination therapy and muscle mass maintenance owenhaskins Aug 6, 2025 3 min read Allurion Technologies has revealed a strategic direction with an increasing focus on low-dose GLP-1 combination therapy, muscle mass maintenance and US market entry
Whether youre using these medications to manage Type 2 diabetes, support weight loss, or address other health concerns, factors like your activity level, metabolic needs, and medical history all play a role in determining the right amount of carbs for you
Thats because private insurance companies often follow suit after Medicare starts covering medications, Moore said
The medication has consistently demonstrated significant weight loss effects in clinical trials
To view or add a comment, sign in 151,430 followers
How Does GLP 1 Clinic Support Work With Dallas BBQ And Tex-Mex